Insider · CIK 0001966698

Grimaud Brett A.

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001966698

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-23	TBPHTheravance Biopharma, Inc.D Disposition to Issuer	SVP, GEN COUNSEL AND SECRETARY	DDisposition to Issuer	−23.4K sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc.D Disposition to Issuer	SVP, GEN COUNSEL AND SECRETARY	DDisposition to Issuer	−108K sh	—	—	23,439
2026-09-23	TBPHTheravance Biopharma, Inc.D Disposition to Issuer	SVP, GEN COUNSEL AND SECRETARY	DDisposition to Issuer	−224K sh	—	—	131,251
2026-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, GEN COUNSEL AND SECRETARY	FTax Payment	−7,952 sh	$16.95	−$135K	355,168
2026-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, GEN COUNSEL AND SECRETARY	FTax Payment	−8,829 sh	$16.55	−$146K	363,120
2026-04-01	TBPHTheravance Biopharma, Inc.A Award	SVP, GEN COUNSEL AND SECRETARY	AAward	+37.5K sh	—	—	371,949
2026-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, GEN COUNSEL AND SECRETARY	FTax Payment	−20.8K sh	$19.66	−$410K	334,449
2025-11-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, GEN COUNSEL AND SECRETARY	FTax Payment	−19K sh	$17.90	−$341K	355,282
2025-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, GEN COUNSEL AND SECRETARY	FTax Payment	−9,762 sh	$13.39	−$131K	374,306
2025-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, GEN COUNSEL AND SECRETARY	FTax Payment	−9,743 sh	$9.45	−$92.1K	384,068
2025-02-28	TBPHTheravance Biopharma, Inc.A Award	SVP, GEN COUNSEL AND SECRETARY	AAward	+75K sh	—	—	393,811
2025-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, GEN COUNSEL AND SECRETARY	FTax Payment	−14.5K sh	$9.66	−$140K	318,811
2024-11-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, GEN COUNSEL AND SECRETARY	FTax Payment	−9,268 sh	$9.97	−$92.4K	333,345
2024-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, GEN COUNSEL AND SECRETARY	FTax Payment	−9,268 sh	$8.22	−$76.2K	342,613
2024-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, GEN COUNSEL AND SECRETARY	FTax Payment	−9,268 sh	$9.10	−$84.3K	351,881
2024-04-02	TBPHTheravance Biopharma, Inc.A Award	SVP, GEN COUNSEL AND SECRETARY	AAward	+100K sh	—	—	360,684
2024-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, GEN COUNSEL AND SECRETARY	FTax Payment	−17.6K sh	$8.92	−$157K	260,684
2023-11-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, GEN COUNSEL AND SECRETARY	FTax Payment	−7,363 sh	$10.37	−$76.4K	278,279
2023-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, GEN COUNSEL AND SECRETARY	FTax Payment	−8,912 sh	$9.70	−$86.4K	285,297
2023-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, GEN COUNSEL AND SECRETARY	FTax Payment	−11.5K sh	$11.21	−$129K	294,209
2023-03-01	TBPHTheravance Biopharma, Inc.A Award	SVP, GEN COUNSEL AND SECRETARY	AAward	+75K sh	—	—	304,958
2023-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, GEN COUNSEL AND SECRETARY	FTax Payment	−10.2K sh	$10.44	−$106K	229,958

Recent filings

Accepted (ET)
Sep 244
Grimaud Brett A.0001966698-26-000011
SEC(opens sec.gov)
Aug 244
Grimaud Brett A.0001966698-26-000008
SEC(opens sec.gov)
May 224
Grimaud Brett A.0001966698-26-000006
SEC(opens sec.gov)
Apr 34
Grimaud Brett A.0001966698-26-000004
SEC(opens sec.gov)
Feb 244
Grimaud Brett A.0001966698-26-000002
SEC(opens sec.gov)
Nov 244
Grimaud Brett A.0001966698-25-000006
SEC(opens sec.gov)
Aug 224
Grimaud Brett A.0001415889-25-022797
SEC(opens sec.gov)
May 224
Grimaud Brett A.0001415889-25-014259
SEC(opens sec.gov)
Mar 44
Grimaud Brett A.0001415889-25-006670
SEC(opens sec.gov)
Feb 244
Grimaud Brett A.0001415889-25-005349
SEC(opens sec.gov)
Nov 224
Grimaud Brett A.0001415889-24-027567
SEC(opens sec.gov)
Aug 224
Grimaud Brett A.0001415889-24-022086
SEC(opens sec.gov)
May 224
Grimaud Brett A.0001415889-24-014135
SEC(opens sec.gov)
Apr 44
Grimaud Brett A.0001415889-24-010322
SEC(opens sec.gov)
Feb 224
Grimaud Brett A.0001415889-24-004962
SEC(opens sec.gov)
Nov 224
Grimaud Brett A.0001415889-23-015450
SEC(opens sec.gov)
Aug 224
Grimaud Brett A.0001415889-23-012517
SEC(opens sec.gov)
May 234
Grimaud Brett A.0001415889-23-008672
SEC(opens sec.gov)

Companies

Theravance Biopharma, Inc.SVP, GEN COUNSEL AND SECRETARYTBPH

Address

C/O THERAVANCE BIOPHARMA US, LLC 901 GATEWAY BLVD

SOUTH SAN FRANCISCO, CA, 94080